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Ironside, A. G., Brennand, J., Mandal, B. K., and Heyworth, B. (1971) . Archives of Disease in Childhood, 46, 815. Cross-infection in infantile gastroenteritis. It is not entirely possible to prevent hospital cross-infection in infantile gastroenteritis by the use of conventional barrier-nursing techniques, even with experienced staff in well-designed wards. An incident of double cross-infection due to enteropathic Esch. coli types 0119 and 0126 and the measures that were taken to control it are described. The type 0119 infections were clinically severe, and the cases showed significant levels of serum antibody to the organism, while the type 0126 infections were clinically mild and no antibody was produced. The use of the antibiotic colistin, to which both organisms were originally sensitive, may have been of some value in clearing the type 0119 infection but was without effect on the type 0126 infection, which continued to spread during treatment. A degree of resistance to colistin was found in some strains of the type 0126 organism isolated after treatment. The outbreaks largely ended spontaneously, but may After the antibiotic trial, 16 of the babies continued to do well and gain weight; the last baby was severely affected by mucoviscidosis and deteriorated and died from respiratory infection 2 months later. No further cases of cross-infection occurred in thegroup before discharge from hospital.
Discussion
This outbreak of hospital cross-infection appeared to be self-limiting, though the administrative measures referred to may have helped to limit the extent. The results of the antibiotic trial were difficult to interpret. The elimination of the original pathogens might have been expected by the process of natural clearance, but the excretion of Esch. coli type 0119 cleared up more completely than might otherwise have been expected, so the colistin may have been helpful in eradicating this organism. The Esch. coli type 0126 infection was in an earlier spreading phase and the antibiotics was not helpful in eradicating the organism or in controlling the spread to new cases. There was little effect in the 3 salmonella cases which were in the convalescent carrier stage.
The transient occurrence of serum antibodies in the clinically severe type 0119 infections was an unusual finding and may have been a reflection of more severe tissue involvement in these cases. This was a useful confirmatory test of the aetiology and, with further experience, may prove to be useful in similar circumstances.
There has been some controversy in recent years over the value of antibiotics in the management of infantile gastroenteritis. The simplest issue is whether antibiotics can eliminate enteropathic Esch. coli from the bowel. A previous report from this department (Heyworth, 1970) showed a clearance rate of about 50% in both colistin-treated cases and untreated controls. In another series (Lamb, 1968) (British Medical Journal, 1970) and that their routine use in this condition is a form of environmental pollution. The main published work is the multicentre controlled trials carried out by the Medical Research Council (1953) . The conclusions of these trials were that sulphadiazine, and to a lesser extent chloramphenicol, could prevent mild cases from becoming severe and could shorten the course of the illness, while chlortetracycline could do the former but not the latter. Apart from the fact that the two most recommended drugs are no longer used in the disease, the trial itself showed disquieting irregularities. In one centre comparing chlortetracycline treated and control cases, the 50 control cases received sulphadiazine in 27 instances, chlortetracyline or chloramphenicol in 13 instances, and penicillin or streptomycin in 20 instances. In spite of the fact that the 'controls' received more antibiotics than the treatment group, the results from this centre provided the only significant advantage for chlortetracycline in the entire trial. Apart from these irregularities, some of the data in the trial suggest that the aetiology of the disease has changed in the past 20 years. The incidence of the two types of enteropathic Esch. coli known then averaged 37% and was as high as 80% in some centres in the M.R.C. trial. This is quite different from the recently reported incidence of 4% of these original serotypes (Ironside, Tuxford, and Heyworth, 1970) and overall incidences of the 10 currently recognized pathogenic types of 16-22% (Ironside et al., 1970 ) and 12-20% .
As most of the recently published work has been of series of inadequate size or without adequate controls, there appears to be a need for a large modern controlled trial to reassess the value of antibiotics in infantile gastroenteritis.
